William Blair & Company’s Inhibikase Therapeutics IKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $306K | Buy |
156,953
+1,000
| +0.6% | +$1.95K | ﹤0.01% | 1252 |
|
|
2025
Q1 | $342K | Buy |
155,953
+21,000
| +16% | +$46K | ﹤0.01% | 1206 |
|
|
2024
Q4 | $439K | Buy |
134,953
+8,833
| +7% | +$28.7K | ﹤0.01% | 1135 |
|
|
2024
Q3 | $164K | Buy |
126,120
+10,000
| +9% | +$13K | ﹤0.01% | 1474 |
|
|
2024
Q2 | $141K | Buy |
116,120
+39,519
| +52% | +$47.8K | ﹤0.01% | 1463 |
|
|
2024
Q1 | $165K | Buy |
76,601
+16,333
| +27% | +$35.3K | ﹤0.01% | 1439 |
|
|
2023
Q4 | $76.5K | Buy |
60,268
+893
| +2% | +$1.13K | ﹤0.01% | 1537 |
|
|
2023
Q3 | $82.5K | Buy |
59,375
+1,487
| +3% | +$2.07K | ﹤0.01% | 1528 |
|
|
2023
Q2 | $209K | Buy |
57,888
+11,888
| +26% | +$42.9K | ﹤0.01% | 1391 |
|
|
2023
Q1 | $181K | Buy |
46,000
+7,833
| +21% | +$30.9K | ﹤0.01% | 1418 |
|
|
2022
Q4 | $115K | Buy |
38,167
+8,334
| +28% | +$25K | ﹤0.01% | 1467 |
|
|
2022
Q3 | $163K | Buy |
29,833
+25,666
| +616% | +$140K | ﹤0.01% | 1430 |
|
|
2022
Q2 | $19K | Buy |
+4,167
| New | +$19K | ﹤0.01% | 1733 |
|